Inactive Instrument

InnoVision Labs, Inc.

INVS

US45781N1090

Advanced Medical Equipment & Technology

InnoVision Labs, Inc. cancelled the transaction announced on July 1, 2014

July 30, 2017

On July 1, 2017, InnoVision Labs, Inc. (OTCPK:INVS) cancelled the transaction.

Latest news about InnoVision Labs, Inc.

InnoVision Labs, Inc. cancelled the transaction announced on July 1, 2014	17-06-30	CI
InnoVision Labs, Inc. will Change its Ticker to INVS from GLSO	16-01-22	CI
GlassesOff Inc. has Changed its Name to InnoVision Labs, Inc	16-01-21	CI
GlassesOff Inc. announced that it has received $1.75 million in funding from Ramius Advisors, LLC.	15-09-20	CI
GlassesOff Inc. announced that it expects to receive $1.75 million in funding from Ramius Advisors, LLC and other investors.	15-09-16	CI
InnoVision Labs, Inc. Auditor Raises 'Going Concern' Doubt	15-05-06	CI
GlassesOff Announces Positive Results from ADHD Study	15-05-04	CI
GlassesOff Inc. will Change its Ticker to GLSO from GLSOD	15-04-29	CI
GlassesOff Inc. has Changed its Ticker to GLSO.D from GLSO	15-03-30	CI
GlassesOff Inc. Launches First Localized Language Version of its App for French-Speaking Markets	15-03-23	CI
GlassesOff Inc. Announces Management Changes	14-12-15	CI
InnoVision Labs, Inc. announced that it expects to receive $15 million in funding from Yorkville Advisors Global LP	14-06-30	CI
GlassesOff Inc. Announces Release of its Innovative Mobile Application GlassesOff(TM) for Android-Operated Devices	14-06-30	CI
GlassesOff Seeks Acquisitions	14-05-19	CI
GlassesOff Inc. announced that it has received $5 million in funding from Ramius Advisors, LLC and other investors.	14-05-16	CI
GlassesOff Inc. Announces Successful Completion of iPhone/iPad iOS Soft Commercial Launch	14-03-11	CI
GlassesOff Inc. Launches First iPad Specific Product	14-01-21	CI
GlassesOff Launches Application for Eliminating Dependency on Reading Glasses	13-12-11	CI
GlassesOff Inc. Appoints Sasson Darwish as Vice Chairman	13-11-05	CI
GlassesOff Inc. has Changed its Ticker to GLSO from ATVP	13-08-12	CI
Autovative Products, Inc. will Change its Ticker to GLSO from ATVP	13-08-12	CI
Autovative Products, Inc. will Change its Name to Glassesoff Inc	13-08-12	CI
Ucansi Inc. announced that it has received $3.11 million in funding.	13-07-30	CI
Ucansi Inc. completed the acquisition of Autovative Products, Inc in a reverse merger transaction.	13-07-29	CI
Ucansi Inc. agreed to acquire Autovative Products, Inc in a reverse merger transaction.	13-07-01	CI

InnoVision Labs, Inc., formerly GlassesOff Inc., is a visual neuroscience software technology company that utilizes technology to develop and commercialize consumer-oriented software applications for improving, through exercise, vision sharpness and vision performance by improving the image processing function in the visual cortex of the brain. It offers scientific products through a game-like experience based on mobile applications. Its products include GlassesOff and Game Vision. GlassesOff application eliminates, through exercise, the dependency on reading glasses of people over the age of 40 who experience natural age-related changes in their near vision sharpness. The GlassesOff application is implemented on the Apple iPhone operating system (iOS) platform (iPhone, iPod and iPad) and the Android platform. Game Vision is a personalized software visual cortex exercise solution to train users' vision parameters critical for sports performance.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Medical Software & Technology Services

	1st Jan change	Capi.
VEEVA SYSTEMS INC.	+5.70%	32.88B
PRO MEDICUS LIMITED	+16.27%	7.84B
SECTRA AB	+22.71%	3.95B
EVOLENT HEALTH, INC.	-17.95%	3.11B
OMNICELL, INC.	-19.93%	1.38B
LUNIT INC.	-30.65%	1.21B
SIMULATIONS PLUS, INC.	+4.36%	933M
B-SOFT CO.,LTD.	-34.81%	911M
VERADIGM INC.	-26.60%	829M

Medical Software & Technology Services